Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

20 mai 2026 07h00 HE | Source: 4basebio

4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial

Oncology focused biotech to utilise 4basebio’s opDNA® technology to support Phase II clinical trial of immunotherapy candidate Multi-year, seven-figure revenue stream reflecting increased commercial...
20 mai 2026 07h00 HE | Source: 4basebio

Final Results and Notice of AGM

CAMBRIDGE, UK – 20 May 2026 – 4basebio plc (AIM: 4BB), a company pioneering an enzymatically-produced DNA technology serving the next generation genetic medicines markets, announces its audited final...
14 mai 2026 07h00 HE | Source: 4basebio

4basebio Announces Appointment of Chief Financial Officer and Board Changes

Richard Bungay appointed as CFO, bringing a strong track record in fundraising, M&A and partnering for listed and private companies, including two major exits and over $400m raised Cambridge, UK,...
11 mai 2026 07h00 HE | Source: 4basebio

4basebio Launches Enzymatic ssDNA Platform

4basebio PLC ("4basebio" or the "Company") 4basebio Launches Enzymatic ssDNA Platform Overcomes critical manufacturing and performance bottlenecks associated with traditional chemical synthesis,...